Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Volpi, D."'
Autor:
Liu S; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom; Nuffield Department of Obstetrics and Gynaeoclogy, Women's Centre, John Radcliffe Hospital, Oxford, United Kingdom; Department of Obstetrics and Gynecology, Xijing Hospital, Fourth Military Medical University, Xi'an, China., Zheng Y, Volpi D, El-Kasti M, Klotz D, Tullis I, Henricks A, Campo L, Myers K, Laios A, Thomas P, Ng T, Dhar S, Becker C, Vojnovic B, Ahmed AA
Publikováno v:
Cancer [Cancer] 2015 Jan 15; Vol. 121 (2), pp. 202-13. Date of Electronic Publication: 2014 Sep 10.
Autor:
Traquandi G; Nerviano Medical Sciences Srl, Business Unit Oncology, Viale Pasteur 10, 20014 Nerviano, MI, Italy. gabriella.traquandi@nervianoms.com, Ciomei M, Ballinari D, Casale E, Colombo N, Croci V, Fiorentini F, Isacchi A, Longo A, Mercurio C, Panzeri A, Pastori W, Pevarello P, Volpi D, Roussel P, Vulpetti A, Brasca MG
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2010 Mar 11; Vol. 53 (5), pp. 2171-87.
Autor:
Liu, S, Zheng, Y, Volpi, D, El-Kasti, M, Klotz, D, Tullis, I, Henricks, A, Campo, L, Myers, K, Laios, A, Thomas, P, Ng, T, Dhar, S, Becker, C, Vojnovic, B, Ahmed, A
BACKGROUND: Standard biomarker testing of a single macroscopic disease site is unlikely to be sufficient because of tumor heterogeneity. A focus on examining global biomarker expression or activity, particularly in microscopic residual chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f8b4363406be2de5abc02ddc46e73e2d
https://doi.org/10.1002/cncr.29029
https://doi.org/10.1002/cncr.29029
Autor:
Achille Panzeri, Wilma Pastori, Gabriella Traquandi, Daniele Volpi, Anna Vulpetti, Elena Casale, Francesco Fiorentini, Nicoletta Colombo, Antonio Longo, Valter Croci, Maria Gabriella Brasca, Marina Ciomei, Dario Ballinari, Patrick Roussel, Antonella Isacchi, Paolo Pevarello, Ciro Mercurio
Abnormal proliferation mediated by disruption of the mechanisms that keep the cell cycle under control is a hallmark of virtually all cancer cells. Compounds targeting complexes between cyclin-dependent kinases (CDKs) and cyclins (Cy) and inhibiting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dde7585aa44385f708daaa9adada912d
http://hdl.handle.net/10281/17244
http://hdl.handle.net/10281/17244